See more : Innovative International Acquisition Corp. (IOAC) Income Statement Analysis – Financial Results
Complete financial analysis of Kolmar BNH Co., Ltd. (200130.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kolmar BNH Co., Ltd., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Pushpay Holdings Limited (PPH.AX) Income Statement Analysis – Financial Results
- MKD Technology Inc. (MKDWW) Income Statement Analysis – Financial Results
- GameOn Entertainment Technologies Inc. (GET.CN) Income Statement Analysis – Financial Results
- AstraZeneca Pharma India Limited (ASTRAZEN.BO) Income Statement Analysis – Financial Results
- Changchun High-Tech Industries (Group) Inc. (000661.SZ) Income Statement Analysis – Financial Results
Kolmar BNH Co., Ltd. (200130.KQ)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: http://www.kolmarbnh.co.kr
About Kolmar BNH Co., Ltd.
Kolmar BNH Co., Ltd. engages in the research and development of cosmetics, health functional foods, and functional ingredients in South Korea and internationally. It also provides vitamins and minerals, weight control, sports/nutrition, intestinal health, and other products, as well as products for men/women. The company was formerly known as Sun Bio Tech and changed its name to Kolmar BNH Co., Ltd. in 2013. The company was founded in 2004 and is based in Sejong, South Korea. Kolmar BNH Co., Ltd. is a subsidiary of Kolmar Korea Holdings Co., Ltd.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 579.55B | 575.90B | 593.08B | 606.89B | 438.91B | 386.37B | 337.57B | 256.01B | 236.19B | 0.00 |
| Cost of Revenue | 498.55B | 465.31B | 458.32B | 466.17B | 344.76B | 309.73B | 276.69B | 211.46B | 191.65B | 913.96M |
| Gross Profit | 81.00B | 110.59B | 134.76B | 140.72B | 94.14B | 76.63B | 60.88B | 44.54B | 44.54B | -913.96M |
| Gross Profit Ratio | 13.98% | 19.20% | 22.72% | 23.19% | 21.45% | 19.83% | 18.03% | 17.40% | 18.86% | 0.00% |
| Research & Development | 443.19M | 11.64B | 7.70B | 5.38B | 590.77M | 513.51M | 264.53M | 204.57M | 2.84B | 0.00 |
| General & Administrative | 3.03B | 2.13B | 1.82B | 1.86B | 13.79B | 9.91B | 7.19B | 5.45B | 4.84B | 0.00 |
| Selling & Marketing | 14.07B | 12.41B | 15.29B | 8.51B | 5.29B | 7.39B | 4.46B | 2.52B | 2.36B | 0.00 |
| SG&A | 17.10B | 37.19B | 34.64B | 25.65B | 19.09B | 17.30B | 11.65B | 7.97B | 7.20B | 0.00 |
| Other Expenses | 33.21B | -753.76M | -828.31M | -633.71M | -475.88M | -286.70M | -190.34M | -158.22M | -57.78M | 0.00 |
| Operating Expenses | 50.75B | 49.58B | 43.17B | 31.67B | 20.15B | 18.10B | 12.11B | 8.34B | 10.09B | 21.26M |
| Cost & Expenses | 549.30B | 514.89B | 501.49B | 497.84B | 364.92B | 327.83B | 288.80B | 219.80B | 201.74B | 935.22M |
| Interest Income | 4.88B | 3.11B | 883.52M | 794.36M | 685.25M | 504.76M | 388.33M | 433.02M | 542.01M | 278.44M |
| Interest Expense | 7.38B | 3.19B | 1.85B | 843.16M | 347.09M | 279.17M | 285.42M | 85.93M | 180.00 | 130.17M |
| Depreciation & Amortization | 16.51B | 14.52B | 11.52B | 8.49B | 5.21B | 4.14B | 3.44B | 2.15B | 1.88B | 913.96M |
| EBITDA | 50.51B | 75.64B | 103.17B | 117.64B | 79.28B | 62.68B | 62.69B | 38.84B | 36.33B | 409.48M |
| EBITDA Ratio | 8.72% | 13.11% | 17.39% | 19.37% | 18.04% | 16.22% | 15.46% | 14.98% | 15.38% | 0.00% |
| Operating Income | 30.26B | 61.01B | 91.59B | 109.05B | 73.99B | 58.54B | 48.77B | 36.21B | 34.45B | -913.96M |
| Operating Income Ratio | 5.22% | 10.59% | 15.44% | 17.97% | 16.86% | 15.15% | 14.45% | 14.14% | 14.58% | 0.00% |
| Total Other Income/Expenses | -4.27B | -4.51B | 281.34M | 515.53M | -1.89B | 5.69B | 10.20B | 1.84B | -23.62B | 3.66B |
| Income Before Tax | 25.99B | 56.62B | 92.41B | 109.78B | 72.19B | 64.23B | 58.97B | 36.61B | 10.16B | -892.70M |
| Income Before Tax Ratio | 4.48% | 9.83% | 15.58% | 18.09% | 16.45% | 16.62% | 17.47% | 14.30% | 4.30% | 0.00% |
| Income Tax Expense | 7.25B | 15.46B | 23.53B | 29.59B | 17.30B | 14.91B | 11.53B | 8.76B | 9.98B | 66.70M |
| Net Income | 19.71B | 40.51B | 69.87B | 80.48B | 54.48B | 48.35B | 45.77B | 29.71B | 1.13B | -826.00M |
| Net Income Ratio | 3.40% | 7.03% | 11.78% | 13.26% | 12.41% | 12.51% | 13.56% | 11.60% | 0.48% | 0.00% |
| EPS | 674.49 | 1.37K | 2.37K | 2.72K | 1.84K | 1.64K | 1.55K | 1.01K | 38.88 | -432.58 |
| EPS Diluted | 674.49 | 1.37K | 2.37K | 2.72K | 1.84K | 1.64K | 1.55K | 1.01K | 38.88 | -432.58 |
| Weighted Avg Shares Out | 29.22M | 29.54M | 29.54M | 29.54M | 29.54M | 29.54M | 29.54M | 29.54M | 29.06M | 1.91M |
| Weighted Avg Shares Out (Dil) | 29.22M | 29.54M | 29.54M | 29.54M | 29.54M | 29.54M | 29.54M | 29.54M | 29.06M | 1.91M |
Source: https://incomestatements.info
Category: Stock Reports